Researchers develop way to simplify production of 18F-alfatide

04/9/2013 | MolecularImaging.net

Researchers have devised a kit that uses a fluoride-aluminum complex to ease the production of 18F-alfatide, an agent that can zero in on active tumors in squamous or adenomatous lung carcinoma. The method presented a yield of 42.1%, compared with 5% to 25% for the standard method, according to the study published in The Journal of Nuclear Medicine. The agent is being considered as an alternative to 18F-FPPRGD2, which was recently approved. "Because of the simplicity of the method, an advantage is that additional studies can be easily performed in a single day," researchers said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI